Ознакомительная версия. Доступно 19 страниц из 92
293. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and Management of Adult Coeliac Disease. Guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210–1228
294. Cristofori F, Fontana C, Magista A, et al. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome. A 6-year prospective chort study. JAMA Pediatr 2014. doi:10.1001/jamapediatrics.2013.4984
295. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: Exploring a new clinical entity. Am J Gastroenterol, 24 July 2012. doi:10.1038/ajg.2012.236
296. Lundin KEA, Farstad IN, Sollid LM. Cøliaki – nye kliniske erkjennelser og diagnostiske hjelpemidler. Tidsskr Nor Lægeforen 2003; 123: 3226–9
297. Green PH, Shane E, Rotterdam H, Forde KA, Grossbard L. Significance of unsuspected celiac disease detected at endoscopy. Gastrointest Endosc 2000; 51: 60–65
298. Tursi A, Giorgetti G, Brandimarte G, Rubino E, Lombardi D, Gasbarrini G. Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology 2001; 48: 462–64
299. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126–31
300. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129–33
301. Lo W, Sano K, Lebwohl B, Diamond B, Green PHR. Changing presentation of celiac disease. Dig Dis Sci 2003; 48: 395–98
302. Shah VH, Rotterdam H, Kotler DP, Fasano A, Green PH. All that scallops is not celiac disease. Gastrointest Endosc 2000; 51: 717–20
303. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American Population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011; 106: 1333–9
304. Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol. 2008;42:224–232
305. Bodvarsson S, Jonsdottir I, Freysdottir J, Leonard JN, Fry L, Valdimarsson T. Dermatitis herpetiformis: an autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin. Scand J Immunol 1993; 38: 546–50
306. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol 2010; 9: 318–30
307. Leonard JN, Tucker WF, Fry JS, et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286 (Clin Res Ed): 16–18
308. Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128 (4 Suppl 1): 38–46
309. Rumessen JJ. Serologisk screening for cøliaki. Ugeskr Læger 2004; 166: 2142–4
310. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993; 17: 123–27
311. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517–2524
312. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 152: 168–9
313. Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–61
314. Scotta MS, Salvatore S, Salvatoni A, et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol 1997; 92: 1331–34
315. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330–54
316. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol 2007; 42: 171–8
317. Løvik A, Lundin KEA. «Kostbehandling av cøliaki og dermatitis herpetiformis». Tidsskr Nor Lægeforen 2003; 123: 3237–40
318. Johnson D. Novel Drug for Celiac Disease Reduces GI and Non-GI Symptoms. Digestive Disease Week (DDW) 2014. Abstract 929f. Presented May 7, 2014. http://www.medscape.com/viewarticle/824778?sr…
319. Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol. Rep. (2015) 3 (1): 3–11
320. Ilus T, Kaukinen K, Virta LJ, et al. Incidence of malignancies in diagnosed celiac patients. Am J Gastroenterol 2014; 109(9): 1471–77
321. Fickling WE, McFarlane XA, Bhalla AK, Robertson DAF. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med 2001; 77: 33–6
322. Farthing MJ, Edwards CR, Rees LH, Dawson AM. Male gonadal function in coeliac disease: 1 sexual dysfunction, infertility, and semen quality. Gut 1982; 23: 608–14
323. Thawani SP, Brannagan TH, Lebwohl B, et al. Risk of neuropathy among 28 232 patients with biopsy-verified Celiac disease. JAMA Neurology 2015. doi:10.1001/jamaneurol. 2015.0475
324. Evans KE, Leeds JS, Morley S et.al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci 2010; 55: 2999–3004
325. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215–18
326. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356–61
327. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566–72
328. Sultan AA, Tata LJ, Fleming KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease. Am J Gastroenterol. 2014;109:1653–1661
329. Fagrådet i Norsk Cøliakiforening. Retningslinjer – cøliaki. 2004
330. Vanuytsel, T; et al. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers 2013. 1 (5): e27321
331. Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 91 (1): 151–75
332. Lammers, Karen M.; Lu, Ruliang; Brownley, Julie; Lu, Bao; Gerard, Craig; Thomas, Karen; Rallabhandi, Prasad; Shea-Donohue, Terez; Tamiz, Amir. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135 (1): 194–204.e3
Ознакомительная версия. Доступно 19 страниц из 92
